| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brain, Vol. 113, No. 6, 1597-1628, 1990
© 1990 Guarantors of Brain
research-article |
CLINICAL ASPECTS OF MULTIPLE SCLEROSIS IN NORTH-EAST SCOTLAND WITH PARTICULAR REFERENCE TO ITS COURSE AND PROGNOSIS
Department of Neurology, Aberdeen Royal Infirmary Aberdeen AB9 2ZB, UK
Correspondence to:
Correspondence to: Dr J. G. Phadke, 74 Vasudeo Nagar, Indore-452004 (MP). India
The prognosis and course of multiple sclerosis (MS) and the factors that affect them were assessed in a group of 1055 patients, representing an unselected (epidemiological) sample observed in the north-east (Grampian region) of Scotland for a period ranging between 1 and 60 yrs. In 7% the disease began before the age of 20 yrs, in 12% after the age of 50 yrs, and in the remainder onset was between the ages of 20 and 50 yrs. The male/female ratio was 1:1.8. Mean disease duration in those observed until death (216 patients) was 24.5 yrs, with no significant difference between the sexes. Prognosis was assessed either by the interval between onset and death or by the degree of disability over a defined period of time. Depending on the length of follow-up, just over one-quarter (26%) to over one-third (36.3%) had a benign course and between 8.0 and 17.7% had a poor prognosis. Nearly a third had a remittent (32.8%) or relapsing Cumulative (34%) course and 9% had a progressive course from the start. Several factors were noted to affect the prognosis.
Prognosis was significantly better, independent of sex, in those with (1) an early onset (<40 yrs of age); (2) retrobulbar neuritis or a brainstem lesion or sensory symptoms alone at onset; (3) short duration of initial symptoms (<6 months); (4) a long onset-first relapse interval (>1 yr); (5) a remittent course in the beginning and (6) lack of a family history of MS. The factors which predicted a poor prognosis included: (1) a late onset (>40 yrs of age); (2) progressive course from the start; (3) multiple sites of lesions initially, or a cerebellar or spinal cord lesion at the onset; (4) psychiatric or persistent urinary symptoms at the onset or within 10 yrs; (5) persistent initial symptoms (beyond 1 yr); (6) early first relapse (within 6 months); (7) a family history of MS; (8) social class status IV and V; and (9) bilaterally prolonged visual evoked potential (VEP) P100 latency. Address in childhood and at the onset of the disease, changes in the CSF and CT brain scan were not of predictive value.
Received May 23, 1986. Revised November 8, 1988. Accepted October 3, 1989.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Glad, H. Nyland, J. Aarseth, T Riise, and K. Myhr Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway Multiple Sclerosis, August 1, 2009; 15(8): 942 - 950. [Abstract] [PDF]
|
|
|
|
 |
|
 E. M. Mowry, M. Pesic, B. Grimes, S. Deen, P. Bacchetti, and E. Waubant Demyelinating events in early multiple sclerosis have inherent severity and recovery Neurology, February 17, 2009; 72(7): 602 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Swanton, K. T. Fernando, C. M. Dalton, K. A. Miszkiel, D. R. Altmann, G. T. Plant, A. J. Thompson, and D. H. Miller Early MRI in optic neuritis: The risk for disability Neurology, February 10, 2009; 72(6): 542 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Hirst, G Ingram, R Swingler, D A S Compston, T Pickersgill, and N P Robertson Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis J. Neurol. Neurosurg. Psychiatry, October 1, 2008; 79(10): 1137 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tremlett, Yinshan Zhao, and V. Devonshire Natural history of secondary-progressive multiple sclerosis Multiple Sclerosis, April 1, 2008; 14(3): 314 - 324. [Abstract] [PDF]
|
|
|
|
|
|
E. Leray, S. Morrissey, J. Yaouanq, M. Coustans, E. Le Page, J. Chaperon, and G. Edan Long-term survival of patients with multiple sclerosis in West France Multiple Sclerosis, August 1, 2007; 13(7): 865 - 874. [Abstract] [PDF]
|
|
|
|
|
|
R. Bergamaschi, S. Quaglini, M. Trojano, M. P. Amato, E. Tavazzi, D. Paolicelli, V. Zipoli, A. Romani, A. Fuiani, E. Portaccio, et al. Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score J. Neurol. Neurosurg. Psychiatry, July 1, 2007; 78(7): 757 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Langer-Gould, R. A. Popat, S. M. Huang, K. Cobb, P. Fontoura, M. K. Gould, and L. M. Nelson Clinical and Demographic Predictors of Long-term Disability in Patients With Relapsing-Remitting Multiple Sclerosis: A Systematic Review Arch Neurol, December 1, 2006; 63(12): 1686 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tremlett and V. Devonshire Is late-onset multiple sclerosis associated with a worse outcome? Neurology, September 26, 2006; 67(6): 954 - 959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. West, M. Wyatt, A. High, A. Bostrom, and E. Waubant Are initial demyelinating event recovery and time to second event under differential control? Neurology, September 12, 2006; 67(5): 809 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Confavreux and S. Vukusic Age at disability milestones in multiple sclerosis Brain, March 1, 2006; 129(3): 595 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S L Minden, D Frankel, L Hadden, J Perloff, K P Srinath, and D C Hoaglin The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics Multiple Sclerosis, February 1, 2006; 12(1): 24 - 38. [Abstract] [PDF]
|
|
|
|
|
|
H. Tremlett, D. Paty, and V. Devonshire Disability progression in multiple sclerosis is slower than previously reported Neurology, January 24, 2006; 66(2): 172 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Pittock, W. T. Mayr, R. L. McClelland, N. W. Jorgensen, S. D. Weigand, J. H. Noseworthy, B. G. Weinshenker, and M. Rodriguez Change in MS-related disability in a population-based cohort: A 10-year follow-up study Neurology, January 13, 2004; 62(1): 51 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Eriksson, O. Andersen, and B. Runmarker Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis Multiple Sclerosis, June 1, 2003; 9(3): 260 - 274. [Abstract] [PDF]
|
|
|
|
|
|
C. Confavreux, S. Vukusic, and P. Adeleine Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process Brain, April 1, 2003; 126(4): 770 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M-L Sumelahti, P J Tienari, M Hakama, and J Wikstrom Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses J. Neurol. Neurosurg. Psychiatry, January 1, 2003; 74(1): 25 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M-L Sumelahti, P J Tienari, J Wikstrom, T M Salminen, and M Hakama Survival of multiple sclerosis in Finland between 1964 and 1993 Multiple Sclerosis, August 1, 2002; 8(4): 350 - 355. [Abstract] [PDF]
|
|
|
|
|
|
G. Ramsaransing, N. Maurits, C. Zwanikken, and J. De Keyser Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review Multiple Sclerosis, October 1, 2001; 7(5): 345 - 347. [Abstract] [PDF]
|
|
|
|
|
|
K M Myhr, T Riise, C Vedeler, M W Nortvedt, M Gronning, R Midgard, and H I Nyland Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension Multiple Sclerosis, February 1, 2001; 7(1): 59 - 65. [Abstract] [PDF]
|
|
|
|
|
|
M. A. A. van Walderveen, G. J. Lycklama a Nijeholt, H. J. Ader, P. J. H. Jongen, C. H. Polman, J. A. Castelijns, and F. Barkhof Hypointense Lesions on T1-Weighted Spin-Echo Magnetic Resonance Imaging: Relation to Clinical Characteristics in Subgroups of Patients With Multiple Sclerosis Arch Neurol, January 1, 2001; 58(1): 76 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Confavreux, S. Vukusic, T. Moreau, and P. Adeleine Relapses and Progression of Disability in Multiple Sclerosis N. Engl. J. Med., November 16, 2000; 343(20): 1430 - 1438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. A. Mann, M. B. Davies, M. D. Boggild, J. Alldersea, A. A. Fryer, P. W. Jones, C. Ko Ko, C. Young, R. C. Strange, and C. P. Hawkins Glutathione S-transferase polymorphisms in MS: Their relationship to disability Neurology, February 8, 2000; 54(3): 552 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Andersson, E. Waubant, L. Gee, and D. E. Goodkin Multiple Sclerosis That Is Progressive From the Time of Onset: Clinical Characteristics and Progression of Disability Arch Neurol, September 1, 1999; 56(9): 1138 - 1142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Confavreux, S Vukusic, J Grimaud, and T Moreau Clinical progression and decision making process in multiple sclerosis Multiple Sclerosis, August 1, 1999; 5(4): 212 - 215. [PDF]
|
|
|
|
|
|
T. L. Sorensen, J. L. Frederiksen, H. Bronnum-Hansen, and H. C. Petersen Optic neuritis as onset manifestation of multiple sclerosis: A nationwide, long-term survey Neurology, August 1, 1999; 53(3): 473 - 473. [Abstract] [Full Text]
|
|
|
|
|
|
Z M Levic, I Dujmovic, T Pekmezovic, M Jarebinski, J Marinkovic, N Stojsavljevic, and J Drulovic Prognostic factors for survival in multiple sclerosis Multiple Sclerosis, June 1, 1999; 5(3): 171 - 178. [Abstract] [PDF]
|
|
|
|
 |
|
 R. J. Butterfield, E. P. Blankenhorn, R. J. Roper, J. F. Zachary, R. W. Doerge, J. Sudweeks, J. Rose, and C. Teuscher Genetic Analysis of Disease Subtypes and Sexual Dimorphisms in Mouse Experimental Allergic Encephalomyelitis (EAE): Relapsing/Remitting and Monophasic Remitting/Nonrelapsing EAE Are Immunogenetically Distinct J. Immunol., March 1, 1999; 162(5): 3096 - 3102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gayou, B. Brochet, and V. Dousset Transitional progressive multiple sclerosis: a clinical and imaging study J. Neurol. Neurosurg. Psychiatry, September 1, 1997; 63(3): 396 - 398. [Abstract] [Full Text] [PDF]
|
|